Non-Specific Anticoagulant Reversal Agent

Positive modulator of GABA A receptors

Potent inhibitor of MRSA PK

JBP923 analog, exerting potent therapeutic effect on inflammatory bowel disease (IBD)

Novel, natural auxin efflux inhibitor, promoting lateral root formation

Negative control for VZ185

Polo-like kinase 1 (Plk1) inhibitor

Novel Cell-Permeable STAT3 Inhibitor, targeting the SH2 domain

Biological Active Reagents

Potent and competitive antagonist at the human D3 receptor

Novel potent muscarinic antagonist wirh antimuscarinic antidepressant-like activities, showing modest affinity across the mAChRs when compared to L-687306 and scopolamine

SecA inhibitor, showing antiprotozoal, antibacterial and antifungal effects, inhibiting post-translational protein transport into the endoplasmic reticulum. also Inhibiting ATP-dependant translocation of precursor proteins acrossing a bacterial cell membr

Novel non-ATP competitive allosteric inhibitor of Aurora B kinase, binding in the allosteric site F

Anti-HIF-1alpha agent, inhibiting HIF-1alpha and cellular VEGF proteins

Novel inhibitor of STAT3 activation and dimerization through targeting the phosphotyrosine binding site within the SH2 domain

Stimulator of the production of growth hormone (GH) from the pituitary gland

Long-lasting stimulator of the production of growth hormone (GH) from the pituitary gland

Novel CK2 inhibitor, showing potent CSC inhibitory effects in A549 cells

Novel potent PfNDH2 inhibitor

Novel selective allosteric modulator of the protein kinase CK2, inducing apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 µM) and inhibiting STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945

Potent, reversible, and ATP-competitive inhibitor of casein kinase-2 (CK2)

Novel potent CK2 inhibitor